FDACounsel.com  -- Legal Services -- for the life of a Life Sciences company

RESEARCH & DEVELOPMENT SERVICES -– The Pre-Approval Phases

Clinical Trial and Other Sourcing Agreements
♦ CROs
   • Sponsor Master Services Agreements
   • Clinical trials management
♦ Investigators
♦ Contract Labs
   • Preclinical testing
♦ IRBs
♦ Active Pharmaceutical Ingredient (API) supply sourcing
♦ Component sourcing deals
♦ Medical advisory boards
   • structure
   • function
♦ Consultants
Commercial Agreements – FDA Issues Presented By:
♦ Co-Development Agreements (e.g., future marketing
    partners)
♦ Acquisitions involving pipeline products
♦ Clinical data ownership
Good Clinical Practice (“GCP”) Compliance & Training
♦ SOPs –
   • drafting
   • review
♦ Compliance
   • audits
   • training
♦ HIPAA and privacy considerations
   • implementing procedures in clinical trials
   • consents
♦ State regulatory requirements
Clinical Trial Protocol Reviews
Informed Consent Reviews
Financial Disclosure Requirements – Compliance and Strategies
♦ Federal:  FDA & HHS
♦ Institutional (e.g., university, hospital)
♦ Clinical trial design to minimize conflicts

Investigational New Drug (IND) and Device (IDE) Submissions
♦ Pre-IND and IDE meetings
   • preparation
   • submissions
♦ INDs & IDEs
   • initial filing
   • maintenance during life of the IND – changes
♦ PDUFA, MDUFMA and Application Fees
♦ Device Reclassification Petitions – easing the regulatory
       burden
   • “De Novo” petitions for truly “new” technologies
   • Traditional for pre-’76 devices
New Drug Applications (NDAs), Biologics License Applications
(BLAs), Abbreviated NDAs (ANDAs), Device Pre-Market Approval
(PMAs) Applications and Pre-Market Notification Submissions
(510k’s)
♦ Counseling on requirements
♦ Strategies to maximize approval process
♦ Responding to FDA deficiency letters
♦ Achieving binding agreements with FDA on clinical design
FDA Liaison & Meetings
♦ End-of-Phase meetings (I, II, III)
♦ Advisory Committee preparation and meetings
Promotion and Advertising During R&D
♦ Reviews
♦ Training
Emerging FDA Issues & Their Impact on Development Plans
♦ Comment preparation on FDA initiatives
♦ Legislative responses
♦ Client-generated strategic initiatives
State Law Issues
Privacy
♦ Medical Records

For "Life Cycle" Stages Legal
Services, Just Click on The
Related Button Below ...

For "Any Time" Legal Services,
Just Click on The Related
Button Below ...

For "Product/Topic Specific"
Legal Services, Just Click on
The Related Button Below ...

For presentations and articles on Drug & Device Development,
just
click here ...

For presentations and articles on Clinical Research, just click here ...

© 2004 Law Offices of Michael A. Swit.  
ALL RIGHTS RESERVED.

Questions?

Contact us @ 760-815-4762
or
mswit@fdacounsel.com